BFM
DERM icon

Boothbay Fund Management’s Journey Medical DERM Stock Holding History

Boothbay Fund Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Hold
67,442
– – 0.01% 1523
2026
Q1 		$316K Hold
67,442
– – ﹤0.01% 1586
2025
Q4 		$520K Buy
+67,442
New +$529K 0.01% 1119

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Boothbay Fund Management's DERM Position: Q2 2026 in Review

Boothbay Fund Management held its Journey Medical (DERM) position steady in Q2 2026 at 67,442 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #1523.

Boothbay Fund Management first reported a position in DERM in Q4 2025 and has held it in 3 quarters since. The position peaked at $520K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Boothbay Fund Management held 67,442 shares of Journey Medical worth $477K as of Q2 2026.
  • Boothbay Fund Management left its Journey Medical share count unchanged in Q2 2026.
  • Journey Medical made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1523 holding.
  • Boothbay Fund Management first reported a position in Journey Medical in Q4 2025 and has held it in 3 quarters since.
  • Boothbay Fund Management's Journey Medical position peaked at $520K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.